Hutchison China Meditech Limited Form-20F Publication

TIDMHCM

Hutchison China Meditech Limited

03 March 2020

Press release

Publication of Form 20-F

London: Tuesday, March 3, 2020: Hutchison China MediTech Limited ("Chi-Med") (NasdaqAIM: HCM) today published the Form 20-F for the financial year ended December 31, 2019. This is available for viewing at http://www.rns-pdf.londonstockexchange.com/rns/8821E_1-2020-3-3.pdf and also on the website of the Company at www.chi-med.com .

About Chi-Med

Chi-Med (Nasdaq/AIM: HCM) is an innovative biopharmaceutical company committed, over the past twenty years, to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. It has a portfolio of eight cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. For more information, please visit: www.chi-med.com .

CONTACTS

 
Investor Enquiries 
  Mark Lee, Senior Vice President                                   +852 2121 8200 
  Annie Cheng, Vice President                                       +1 (973) 567 3786 
  David Dible, Citigate Dewe Rogerson                               +44 7967 566 919 (Mobile) 
                                                                    david.dible@citigatedewerogerson.com 
  Xuan Yang, Solebury Trout                                         +1 (415) 971 9412 (Mobile) 
                                                                     xyang@troutgroup.com 
 
Media Enquiries 
  UK & Europe - Anthony Carlisle, Citigate Dewe Rogerson            +44 7973 611 888 (Mobile) 
                                                                     anthony.carlisle@cdrconsultancy.co.uk 
  Americas - Brad Miles, Solebury Trout                             +1 (917) 570 7340 (Mobile) 
                                                                     bmiles@troutgroup.com 
  Asia         - Joseph Chi Lo, Brunswick                           +852 9850 5033 (Mobile) 
                                                                     jlo@brunswickgroup.com 
               - Zhou Yi, Brunswick                                 +852 97 83 6894 (Mobile) 
                                                                     y zhou@brunswickgroup.com 
 
Nominated Advisor 
  Freddy Crossley / Atholl Tweedie, Panmure Gordon (UK) Limited     +44 (20) 7886 2500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRAJJMITMTMMBIM

(END) Dow Jones Newswires

March 03, 2020 09:18 ET (14:18 GMT)

Hutchison China Meditech (LSE:0J7G)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024